Procaps Group, S.A PE Ratio 2020-2023 | PROCF
Current and historical p/e ratio for Procaps Group, S.A (PROCF) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Procaps Group, S.A PE ratio as of February 07, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Procaps Group, S.A PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-02-03 |
1.01 |
|
2.15 |
| 2023-09-30 |
3.62 |
$0.47 |
7.70 |
| 2023-03-31 |
4.51 |
$0.32 |
14.09 |
| 2022-12-31 |
5.25 |
$0.41 |
12.80 |
| 2022-09-30 |
7.00 |
$0.31 |
22.58 |
| 2022-06-30 |
9.32 |
$0.09 |
103.56 |
| 2022-03-31 |
8.50 |
$0.43 |
19.77 |
| 2021-12-31 |
9.75 |
$0.27 |
36.11 |
| 2021-09-30 |
10.20 |
$0.27 |
37.78 |
| 2023-06-30 |
4.30 |
$0.27 |
15.93 |
| 2021-06-30 |
10.09 |
0 |
0.00 |
| 2021-03-31 |
10.05 |
0 |
0.00 |
| 2020-12-31 |
10.40 |
0 |
0.00 |
| 2020-09-30 |
9.93 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
